Zoetis Inc. (FRA:ZOE)
128.68
+0.22 (0.17%)
Last updated: Sep 9, 2025, 11:24 AM CET
Zoetis Revenue
Zoetis had revenue of $2.46B USD in the quarter ending June 30, 2025, with 4.19% growth. This brings the company's revenue in the last twelve months to $9.39B, up 5.27% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.39B
Revenue Growth
+5.27%
P/S Ratio
7.16
Revenue / Employee
$680.07K
Employees
13,800
Market Cap
57.24B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Rheinmetall AG | 10.67B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Zoetis News
- 20 hours ago - Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 days ago - Top 50 High-Quality Dividend Stocks For September 2025 - Seeking Alpha
- 6 days ago - ZOE Released White Paper on European VPP and Energy Storage Development - Wallstreet:Online
- 7 days ago - Phibro Animal Health: Zoetis Growth, Valuation Still Attractive - Seeking Alpha
- 8 days ago - Zoetis: A Solid Dividend Growth Investment For The Long Haul - Seeking Alpha
- 12 days ago - Phibro targets 10–14% sales growth for 2026 as Zoetis integration and Phibro Forward drive momentum - Seeking Alpha
- 13 days ago - Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
- 15 days ago - Zoetis: Why I Decided To Invest In The Stock - Seeking Alpha